To The Moon

Centrus Energy has become the nuclear market’s ultimate argument starter.

The bulls see a strategically indispensable US fuel supplier sitting at the intersection of nuclear revival, energy security and AI’s insatiable appetite for electricity. The bears see an expensive stock whose current earnings barely justify the valuation, let alone the enormous future investors have already begun to price in.

Then there is the share price.

LEU closed at $173.89 on 4 September, down more than 62% from its 52-week high of $464.25. That is not a routine pullback. It is a full-scale demolition of the momentum trade. Yet the underlying strategic case has hardly been demolished with it.

That disconnect is what makes Centrus so interesting now.

The stock collapsed. The strategic bottleneck did not

From nuclear darling to market punchbag

The broader nuclear complex has suffered a brutal reversal after its spectacular run-up. LEU has been caught squarely in it, creating a strange situation where a company can be more strategically important while becoming dramatically cheaper.

Short interest helps explain the intensity. Depending on the data source and calculation date, roughly 22.3% to 28.1% of LEU's float is short. That puts Centrus firmly in contested territory: long-term nuclear believers on one side, investors betting that expectations have outrun economics on the other.

Wall Street is hardly unanimous either. Analyst targets range from roughly $216 to $280, while the spreadsheet's consensus target is $248.28, implying 42.78% upside from the latest close.

That is a sizeable potential return. It is also worth remembering that analysts are attempting to value a business whose earnings can move around dramatically from quarter to quarter. Predicting a nuclear-fuel company's earnings several years out is not quite the same as predicting the weather next Tuesday.

LEU's volatility tells a story the headline price cannot

The fuel bottleneck matters more than the uranium

Centrus's real asset is not simply uranium. It is enrichment capability.

The company remains the only domestic entity licensed by the US Nuclear Regulatory Commission to enrich High-Assay Low-Enriched Uranium, or HALEU.

That distinction could become enormously valuable.

Advanced reactors and many next-generation SMRs require HALEU, while the Western nuclear industry is attempting to reduce its dependence on Russian nuclear-fuel infrastructure. Creating new enrichment capacity is not something that happens because somebody spots an attractive market multiple on a Bloomberg terminal.

It requires specialist technology, regulatory approvals, infrastructure, capital and years.

Centrus therefore occupies a strategically awkward but potentially lucrative position. If advanced nuclear succeeds, fuel availability becomes a prerequisite rather than an optional extra.

The company is effectively selling the picks and shovels to a gold rush in which the government is also standing behind the mine.

AI's electricity problem is nuclear's opportunity

The AI boom adds another layer.

Hyperscalers are searching for reliable, round-the-clock electricity to support increasingly power-hungry data centres. Nuclear offers something intermittent renewables cannot provide on their own: firm generation with very low operational carbon emissions.

That does not mean every data centre will suddenly be powered by an SMR. Nor should investors assume every proposed reactor will be built on schedule.

But the direction of travel matters. Big technology companies have given nuclear power a level of commercial validation that would have seemed improbable only a few years ago.

For $Centrus(LEU)$, the critical question is what happens when nuclear ambition collides with fuel reality.

The financials are where the argument gets uncomfortable

Here I think the bears deserve considerable respect.

Trailing revenue reached $473.9 million, up 8.5%, but net income fell 53.7% to $48.5 million. Diluted EPS declined 64.7% to $2.17.

Operating income tells an even more sobering story. It fell from $43.4 million in FY2025 to just $0.5 million on a trailing basis, leaving an operating margin of barely 0.1%.

Yet LEU trades at 80.01 times trailing earnings and 71.25 times forward earnings. Its price-to-sales ratio is 7.32 times.

Those are extraordinary numbers for a company generating less than half a billion dollars of annual revenue.

Free cash flow is currently negative $163.8 million, compared with positive $31.3 million in FY2025. Operating cash flow has also swung negative, to $55 million outflow.

The reason is partly investment for the future. Capital expenditure has risen to $108.8 million from just $19.7 million in FY2025.

Building the future is expensive; investors must decide what comes next

This is the crucial financial tension: Centrus is spending today on an industry that investors believe will become dramatically larger tomorrow.

The backlog is real. So is the execution risk.

The latest figures make the long-term bull case much easier to understand.

Centrus has a total backlog of approximately $4.5 billion, comprising $3.7 billion in its LEU segment and $800 million in Technical Solutions. The LEU backlog alone is more than ten times the company's $367.2 million of trailing LEU segment revenue.

That is significant.

But backlog is not revenue, and revenue is certainly not free cash flow.

The timing of enrichment deliveries can make quarterly results exceptionally lumpy. Centrus's recent earnings illustrate the point: its second-quarter adjusted EPS came in at $1.77 against expectations of $0.97, producing precisely the sort of violent quarterly swing that delights momentum traders and irritates fundamental analysts.

The market is therefore attempting to look through today's financial volatility towards a much larger future earnings base.

That may prove correct. It also explains why the valuation remains so contentious.

Competitive moat, with an asterisk

Centrus has a formidable position, but I would stop short of calling it an impregnable monopoly.

Urenco has enormous Western enrichment expertise. Orano is another major European nuclear-fuel player. Russian supplier Rosatom remains globally significant, although geopolitical considerations make Russian dependence increasingly unattractive to the US and its allies.

Centrus's competitive advantage is therefore a combination of technology, licensing, domestic capacity and geopolitics.

That combination is powerful.

But if HALEU becomes a genuinely enormous market, governments will have every incentive to encourage additional Western capacity. Today's scarcity could attract tomorrow's competitors.

The moat is therefore real, but investors should value it as a strategic advantage rather than assume it is a permanent licence to print money.

The balance sheet buys time

One underappreciated strength is Centrus's balance sheet.

Cash and equivalents stood at $1.87 billion at June 2026, while long-term debt was $1.18 billion, leaving net cash of roughly $691 million.

That gives the company considerable financial flexibility as it attempts to scale its enrichment ambitions.

There is, however, a shareholder cost. Shares outstanding have risen substantially, and the company issued $437.7 million of common stock during the latest trailing period.

So while $Centrus(LEU)$ has plenty of financial ammunition, existing shareholders should not assume all of the future upside will accrue to today's share count.

Nuclear infrastructure may be strategic. Dilution remains dilution.

A utility wearing a tech-stock costume

This is where I think the market has made LEU unusually difficult to value.

Centrus is being traded as though it were a high-beta technology stock, complete with AI enthusiasm, momentum investors, enormous expectations and a short-interest problem.

Yet underneath that volatility sits something much more prosaic and potentially more durable: critical energy infrastructure with government-backed strategic demand.

That is why the 62% drawdown is so intriguing.

If the nuclear thesis has genuinely broken, today's valuation may still be far too high. But if the nuclear thesis is merely going through a violent repricing while HALEU becomes increasingly indispensable, the market may eventually discover that it has thrown out the strategic asset with the speculative bathwater.

I would not dismiss the bears. An 80-times earnings multiple, negative free cash flow and substantial execution requirements demand humility.

But I also would not confuse today's earnings with Centrus's ultimate economic potential.

For me, LEU is best understood as a utility disguised as a high-beta tech stock. That makes it neither an obvious bargain nor an obvious bubble.

It makes it a particularly interesting battleground.

Wall Street sees a stock. The grid sees a bottleneck

And in a market where everyone suddenly agrees on AI, perhaps the most interesting investment is the one where nobody can agree on what the electricity behind it is worth.

@TigerStars @Daily_Discussion @Tiger_comments @Tiger_SG @Tiger_Earnings @TigerClub @TigerWire